Pilot, open-label, single-arm clinical trial evaluating the efficacy of topical crisaborole for steroid refractory morphea.
Publication
, Journal Article
Petty, AJ; Emge, DA; Blanchard, SK; Selim, MA; Scoggins, K; Liu, B; Green, CL; Cardones, AR
Published in: J Am Acad Dermatol
August 2023
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Am Acad Dermatol
DOI
EISSN
1097-6787
Publication Date
August 2023
Volume
89
Issue
2
Start / End Page
390 / 392
Location
United States
Related Subject Headings
- Treatment Outcome
- Scleroderma, Localized
- Ointments
- Humans
- Dermatology & Venereal Diseases
- Dermatitis, Atopic
- Bridged Bicyclo Compounds, Heterocyclic
- Boron Compounds
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Petty, A. J., Emge, D. A., Blanchard, S. K., Selim, M. A., Scoggins, K., Liu, B., … Cardones, A. R. (2023). Pilot, open-label, single-arm clinical trial evaluating the efficacy of topical crisaborole for steroid refractory morphea. J Am Acad Dermatol, 89(2), 390–392. https://doi.org/10.1016/j.jaad.2023.03.052
Petty, Amy J., Drew A. Emge, Sarah K. Blanchard, Maria Angelica Selim, Kim Scoggins, Beiyu Liu, Cynthia L. Green, and Adela R. Cardones. “Pilot, open-label, single-arm clinical trial evaluating the efficacy of topical crisaborole for steroid refractory morphea.” J Am Acad Dermatol 89, no. 2 (August 2023): 390–92. https://doi.org/10.1016/j.jaad.2023.03.052.
Petty AJ, Emge DA, Blanchard SK, Selim MA, Scoggins K, Liu B, et al. Pilot, open-label, single-arm clinical trial evaluating the efficacy of topical crisaborole for steroid refractory morphea. J Am Acad Dermatol. 2023 Aug;89(2):390–2.
Petty, Amy J., et al. “Pilot, open-label, single-arm clinical trial evaluating the efficacy of topical crisaborole for steroid refractory morphea.” J Am Acad Dermatol, vol. 89, no. 2, Aug. 2023, pp. 390–92. Pubmed, doi:10.1016/j.jaad.2023.03.052.
Petty AJ, Emge DA, Blanchard SK, Selim MA, Scoggins K, Liu B, Green CL, Cardones AR. Pilot, open-label, single-arm clinical trial evaluating the efficacy of topical crisaborole for steroid refractory morphea. J Am Acad Dermatol. 2023 Aug;89(2):390–392.
Published In
J Am Acad Dermatol
DOI
EISSN
1097-6787
Publication Date
August 2023
Volume
89
Issue
2
Start / End Page
390 / 392
Location
United States
Related Subject Headings
- Treatment Outcome
- Scleroderma, Localized
- Ointments
- Humans
- Dermatology & Venereal Diseases
- Dermatitis, Atopic
- Bridged Bicyclo Compounds, Heterocyclic
- Boron Compounds
- 3202 Clinical sciences
- 1103 Clinical Sciences